白血病,骨髓,慢性,非典型,BCR-ABL阴性的临床试验
总计9992个结果
-
Bristol-Myers Squibb撤销
-
Gruppo Italiano Malattie EMatologiche dell'Adulto主动,不招人
-
Newcastle UniversityBristol-Myers Squibb; Institute of Cancer Research, United Kingdom; Newcastle-upon-Tyne Hospitals... 和其他合作者完全的
-
National Cancer Institute (NCI)终止
-
Centre Hospitalier Universitaire de Besancon完全的
-
Nanfang Hospital of Southern Medical University招聘中
-
Centre Hospitalier Universitaire de Besancon完全的
-
Teva Branded Pharmaceutical Products R&D, Inc.终止慢性粒细胞白血病美国, 比利时, 法国, 大韩民国
-
University of British ColumbiaBristol-Myers Squibb完全的
-
University Health Network, Toronto未知
-
Bristol-Myers Squibb完全的
-
Novartis Pharmaceuticals终止Philadelphia Positive (Ph+) Chronic Myeloid Leukemia俄罗斯联邦
-
Prof. Dr. Nikolas von BubnoffNovartis终止
-
Merck Sharp & Dohme LLC终止
-
Amsterdam UMC, location VUmcMerck Sharp & Dohme LLC; Novartis; Uppsala University Hospital终止
-
University of LiverpoolImperial College London; Newcastle University; University of Glasgow未知
-
Kanto CML Study GroupEpidemiological and Clinical Research Information Network完全的
-
CttqRuijin Hospital未知
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
University of BolognaNovartis; Schering-Plough终止
-
Poitiers University HospitalNovartis完全的
-
Institut BergoniéNovartis终止
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)完全的